Estrogen Antagonists: all 386 studies that test it
Page 4 of 4. Open to participants first (38), then studies with results posted, then the rest; newest registration first within each.
- Clomiphene Citrate in Infertile PCOS PatientsWithdrawnNCT00501839Phase 4
- Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant GliomasStatus unknownNCT00492687Phase 2
- Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III MelanomaStatus unknownNCT00492505Phase 2
- Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular MelanomaStatus unknownNCT00489944Phase 2
- Letrozole Versus Clomifene Citrate for Ovulation InductionCompletedNCT00478504Phase 4
- Treatment of Anovulatory Infertility in PCOS PatientsCompletedNCT00471523Phase 4
- Strategies for Ovulation Induction in Anovulatory Infertile Patients With PCOSStatus unknownNCT00461643Phase 4
- Tamoxifen Compared With Clomiphene Citrate for Women Who Had Thin Endometrium Women Under Clomiphene in a Previous CycleStatus unknownNCT00449514Not applicable
- Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal FibrosisStatus unknownNCT00440349Phase 2
- The Effect of Metformin Added to Clomiphene Citrate on Pregnancy Rates in Hyperandrogenic, Chronic Oligoovulatory or Anovulatory WomenCompletedNCT00413179Phase 3
- Tamoxifen in Treatment of Acute ManiaCompletedNCT00411203Phase 3
- Anti-Estrogen Therapy for Hereditary Hemorrhagic Telangiectasia A Double-Blind Placebo-Controlled Clinical TrialCompletedNCT00375622Phase 2
- Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid TherapyCompletedNCT00371956Phase 4
- Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of SchizophreniaCompletedNCT00361543Phase 4
- Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral EstrogenCompletedNCT00332553Phase 2
- Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive PatientsCompletedNCT00309491Phase 3
- Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive PatientsCompletedNCT00309478Phase 3
- CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving TamoxifenStatus unknownNCT00305838Phase 2
- Tamoxifen-MRI StudyCompletedNCT00295100Phase 2
- ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.CompletedNCT00291759Phase 3
- Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast CancerCompletedNCT00253539Phase 2
- PROACT - Pre-Operative Arimidex Compared To TamoxifenCompletedNCT00232661Phase 3
- Tamoxifen Therapy in Amyotrophic Lateral Sclerosis [ALS]CompletedNCT00214110Phase 2
- Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast CancerTerminatedNCT00210028Phase 2
- Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women?CompletedNCT00206544Phase 2
- Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer PatientsTerminatedNCT00206492Phase 2
- Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of DiseaseCompletedNCT00200174Not applicable
- 2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal OsteoporosisCompletedNCT00191425Phase 4
- Raloxifene Use for The HeartCompletedNCT00190593Phase 3
- A Phase II Study of ZD1839 and Tamoxifen in Patients With Epithelial Ovarian Carcinoma, Cancer of the Fallopian Tube or the Peritoneum Refractory to Platinum- and Taxane-based TherapyCompletedNCT00189358Phase 2
- Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease SurvivorsCompletedNCT00165308Not applicable
- The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)CompletedNCT00152178Phase 3
- AFTER: Altering Fat Through Estrogen and RaloxifeneCompletedNCT00149604Phase 2
- Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the BreastStatus unknownNCT00126464Not applicable
- Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast CancerTerminatedNCT00096369Phase 2
- Effect of 4-Hydroxytamoxifen Gel on Breast Density, Salivary Sex Steroids, and Quality of Life in Premenopausal WomenCompletedNCT00084344Not applicable
- Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast CancerCompletedNCT00080743Phase 2
- Effects of Teriparatide in Postmenopausal Women With OsteoporosisCompletedNCT00079924Phase 4
- Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or AnastrozoleStatus unknownNCT00077168Phase 2
- Treatment of Infertility in Women With Polycystic Ovary SyndromeCompletedNCT00068861Phase 3
- Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's DiseaseCompletedNCT00065767Phase 2/3
- Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast CancerWithdrawnNCT00053339Phase 3
- Tipifarnib Plus Tamoxifen in Treating Women With Metastatic Breast CancerCompletedNCT00052728Phase 2
- Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With OsteoporosisCompletedNCT00046137Phase 3
- Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With OsteoporosisCompletedNCT00035256Phase 4
- Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.CompletedNCT00034125Phase 3
- Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast CancerCompletedNCT00032136Phase 3
- Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast CancerCompletedNCT00031850Not applicable
- Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast CancerCompletedNCT00031811Not applicable
- Examination of Tamoxifen in Acute Mania in Patients With Bipolar I DisorderCompletedNCT00026585Phase 2
- Radiation Therapy and Tamoxifen in Treating Children With Newly Diagnosed Brain Stem GliomaStatus unknownNCT00024336Phase 2
- Raloxifene in Preventing Breast Cancer in Premenopausal WomenCompletedNCT00019500Phase 2
- Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial CancerTerminatedNCT00016341Phase 3
- Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast CancerStatus unknownNCT00010140Phase 3
- Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma MultiformeCompletedNCT00006388Phase 2
- Comparison of Four Different Treatment Regimens in Treating Women With Stage I Breast CancerStatus unknownNCT00006030Phase 3
- Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast CancerCompletedNCT00005886Phase 1
- Randomized Study of the Effect of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Obese Women With Polycystic Ovary SyndromeCompletedNCT00005654Not applicable
- Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary SyndromeCompletedNCT00005104Not applicable
- Raloxifene in Treating Patients With Persistent or Recurrent Endometrial CancerCompletedNCT00004915Phase 2
- Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast CancerCompletedNCT00004205Phase 3
- Danazol in Treating Patients With Advanced or Recurrent Endometrial CancerCompletedNCT00003946Phase 2
- Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal WomenCompletedNCT00003906Phase 3
- Tamoxifen in Treating Women With Breast CancerStatus unknownNCT00003678Phase 3
- Tamoxifen in Treating Patients With Primary Liver CancerCompletedNCT00003424Phase 3
- Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast CancerStatus unknownNCT00003418Phase 3
- Chemoprevention Therapy Plus Surgery in Treating Women With Breast CancerCompletedNCT00003099Phase 2
- Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast CancerStatus unknownNCT00003016Phase 3
- Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast CancerCompletedNCT00002967Phase 3
- Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast CancerCompletedNCT00002864Phase 3
- Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast CancerCompletedNCT00002777Phase 3
- Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I Breast CancerCompletedNCT00002720Phase 3
- Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast CancerCompletedNCT00002646Phase 3
- Tamoxifen for the Prevention of Breast Cancer in High-Risk WomenCompletedNCT00002644Phase 3
- Combination Chemotherapy and Tamoxifen in Treating Patients With Solid TumorsCompletedNCT00002608Phase 2
- Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast CancerCompletedNCT00002582Phase 3
- Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast CancerCompletedNCT00002581Phase 3
- Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast CancerCompletedNCT00002580Phase 3
- Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast CancerCompletedNCT00002579Phase 3
- Tamoxifen in Treating Women With High-Risk Breast CancerCompletedNCT00002542Phase 3
- Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast CancerCompletedNCT00002529Phase 3
- Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast CancerCompletedNCT00002528Phase 3
- Adjuvant Hormone Therapy in Treating Women With Operable Breast CancerStatus unknownNCT00002460Phase 3
- The Safety and Effectiveness of Surgery With or Without Raloxifene for the Treatment of Pelvic Pain Caused by EndometriosisCompletedNCT00001848Phase 2
- A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With OsteosarcomaCompletedNCT00001436Phase 1
- Tamoxifen StudyCompletedNCT00000529Phase 3